Hansa Biopharma AB (HNSBF), a biopharmaceutical company, on Tuesday announced that Richard Philipson has been named Chief Medical Officer with effect from July 14.
Philipson has over 25 years of experience and served as CMO of Calliditas Therapeutics.
On Monday, Hansa Biopharma closed trading, 3.50% lesser at SEK 27.06 on the Stockholm Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.